Despite the immense importance of enzyme-substrate reactions, there is a lack of generic and unbiased tools for identifying and prioritizing substrate proteins which are modulated in the structural and functional levels through modification. Here we describe a high-throughput unbiased proteomic method called System-wide Identification and prioritization of Enzyme . Not surprisingly, mechanisms and kinetics of protein modifications have become a vibrant research area. However, there still has been a lack of methods for prioritization of the substrates undergoing structural changes in terms of the functional impact of the modifications 4, 5 . Furthermore, an important aspect of PTM research is the characterization of enzyme-substrate associations, which is essential for our understanding of cell biology and disease mechanisms. Moreover, many high-throughput screening assays rely upon modified substrates as a readout. The lack of information on the physiological substrates of enzymes hampers the development of effective therapeutics, e.g. showing that this method can reveal known and putative substrates that change their stability upon modification in each system and rank them by the probability of having biological impact. 
At least a third of all proteins possess enzymatic activity. One of the most comprehensive enzyme databases BRENDA comprises >9 million protein sequences and encompasses 6953 classes of enzyme-catalyzed reactions (http://genexplain.com/brenda/) 1 
.
Many of these enzymes catalyze the modifications of protein substrates. Only in human genome, an estimated 1,089 non-metabolic enzymes are present 2 , including for example more than 500 putative kinases. Transient modulation of protein post-translational modifications (PTMs) controls numerous cellular processes by inducing a host of downstream effects, such as changes in protein function, stability, interactions, hemostasis, localization and cellular diversification 3 . Not surprisingly, mechanisms and kinetics of protein modifications have become a vibrant research area. However, there still has been a lack of methods for prioritization of the substrates undergoing structural changes in terms of the functional impact of the modifications 4, 5 . Furthermore, an important aspect of PTM research is the characterization of enzyme-substrate associations, which is essential for our understanding of cell biology and disease mechanisms. Moreover, many high-throughput screening assays rely upon modified substrates as a readout. The lack of information on the physiological substrates of enzymes hampers the development of effective therapeutics, e.g. in Parkinson's disease 6 and cancer 7 .
Existing techniques used for identifying specific substrates are enzyme-specific, laborintensive and often not straightforward. Such experiments include the use of genetic and pharmacologic perturbations 8 , substrate-trapping mutants 9 , affinity purification-mass spectrometry 10 , utilizing peptide 11 or protein arrays 12 , tagging the client proteins by substrate analogues using engineered enzymes 13 and peptide immunoprecipitation 14 or the use of sophisticated computational tools 15 . Most of these techniques are specifically designed for a certain enzyme or enzyme class, which limits their applicability. Engineering enzymes can alter the biology of the system, potentially introducing a bias. Therefore, designing an unbiased, general, quick and proteome-wide method not involving artificial modification of the enzyme or substrate can prove to be a significant methodological advancement and a complement to above approaches.
Mass spectrometry based CEllular Thermal Shift Assay (MS-CETSA) or Thermal
Proteome Profiling (TPP) is a recent method that can assess system-wide protein binding to small molecules, metabolites or nucleic acids by monitoring changes in protein thermal stability 16, 17 . Since PTMs can also alter protein thermal stability, these methods can be potentially used to probe proteome-wide effects of PTMs. For example, Nordlund et al. have shown that phosphorylation leads to extensive intramolecular reorganization and stabilization of retinoblastoma-associated protein 1 (RB1) 18 , while Savitski et al. have shown a correlation between phosphorylation and protein stability in mitosis 19 . By employing CETSA with a Western blot readout at a single protein level, it has been shown that O-GlcNAcylation enhances stability of Nod2 protein 20 .
Huang et al. have recently developed a method called Hotspot Thermal
Profiling that relates shifts in peptide melting temperature in response to site-specific phosphorylation sites (hotspots) 5 . A very important assertion made in this work is that, the larger the shift, the more likely is the biological importance of a given PTM. Therefore, proteome-wide monitoring of the thermal stability changes in the cell lysate upon addition of a recombinant enzyme and a cosubstrate has the potential of not only revealing the enzyme substrates, but also prioritizing them according to the altered stability they demonstrate when undergoing modification. In this paper, substrate is the protein post-translationally modified by the enzyme, while cosubstrate refers to a molecule (such as NADPH, ATP and NAD) that participates in the enzymatic reaction.
In many cases, the concomitant protein-enzyme and protein-cosubstrate interactions can mask modification-specific thermal stability changes of the substrates. This problem is addressed in our method of System-wide Identification and prioritization of Enzyme Substrates by Thermal Analysis (SIESTA). SIESTA identifies specific thermal stability changes induced in substrate proteins by a combination of enzyme and cosubstrate as compared to the changes induced by either enzyme or cosubstrate alone (workflow in Fig. 1 ). The idea of specific response is borrowed from our methods of Functional Identification of Target by Expression Proteomics (FITExP) 21 and ProTargetMiner
22
. In this approach, using orthogonal partial least squares-discriminant analysis (OPLS-DA) 23 , protein Tm in "enzyme + cosubstrate" treatment can be contrasted with those in "control" (cell lysate incubated with vehicle), "enzyme"-treated lysate, and "cosubstrate"-treated lysate. Here, we apply SIESTA to three distinct enzymes,
showing that this method can reveal known and putative substrates that change their stability upon modification in each system and rank them by the probability of having biological impact.
Fig. 1. SIESTA workflow for unbiased proteome-wide identification of enzyme substrates.
A master cell lysate is prepared by multiple freeze-thawing in a non-denaturing buffer. 
RESULTS

SIESTA identified and ranked multiple known and putative TXNRD1 substrates
As the proof of principle, we selected an enzymatic reaction involving an oxidoreductase.
Since such reduction reaction should destabilize substrate proteins and lead to negative ∆Tm, the asymmetry between positive and negative values will be easy to verify. For this reaction we employed human selenoprotein thioredoxin reductase 1 (TXNRD1), a key oxidoreductase that catalyzes the reduction of specific substrate proteins using NADPH as a cosubstrate 24 . A SIESTA experiment was performed in HCT116 cell lysate treated in duplicates with vehicle,
NADPH, TXNRD1, or both (Supplementary Data 1).
Changes in Tm after NADPH treatment revealed stabilization of several known NADPHinteracting proteins (Fig. 2a) , an example of which is shown in Fig. 2b . Among the 40 proteins annotated as NADPH binders in Uniprot database, 30 proteins (75%) were verified in our experiment, which indirectly validated the SIESTA approach (Fig. 2a) . 247 novel proteins were identified as putative NADPH binders (Supplementary Data 2) .
The analysis of specific ∆Tm shifts in the TXNRD1+NADPH treatment revealed that in the presence of NADPH, TXNRD1 destabilized both known and novel candidate substrate proteins (Supplementary Data 3) . In general, the expected asymmetry in Tm shifts in favor of destabilization was well pronounced (Fig. 2c ). An OPLS-DA model contrasting TXNRD1+NADPH with enzyme and cosubstrate single treatments was also used to reveal the specifically shifting proteins and rank them by their shifts and variable influence on projection (VIP)-values (Fig. 2d, Supplementary Data 4) . In OPLS-DA, the VIP-values show the impact each x-variable (i.e. protein) have on the model with a higher value corresponding to a greater contribution 22, 25 . In Supplementary Fig. 1a , the VIP-plot of the top 20 ranked proteins in the TXNRD1 OPLS-DA model are shown with the error bars representing 95% confidence intervals.
Examples of melting curves for proteins destabilized by TXNRD1 are shown in Fig. 2e . . Among the identified TXNRD1 substrates, TXNL1
(or TRP32) 28 and NXN 29 are well known. Note that secondary reactions are unlikely during SIESTA, as the typical cellular volume is diluted ≈77 fold. It should also be noted that cell lysate is usually used for discovery of direct interactions in thermal profiling 30 . Furthermore, if secondary reactions were possible, they would also occur in lysates treated with NADPH alone, and thus would be filtered away in our analysis.
To prove that the identified proteins can be directly reduced by TXNRD1, we designed a sequential iodoTMT labeling approach, with which the reduction/oxidation can be quantitatively analyzed on the single cysteine level. For this purpose we incubated the recombinant candidate proteins GPX1, GPX4, GSTO1, GSTO2, PRDX2, PRDX6 and GULP1 with TXNRD1+NADPH
under the same conditions as in the SIESTA experiment. The results confirmed that GPX1, GPX4, GSTO2, PRDX2 and GULP1 can be directly reduced by TXNRD1 (Fig. 2f, Supplementary Fig. 1b for GPX4 and Supplementary Data 5). For example, in PRDX2 both Cys51 and Cys172, which form an interchain disulfide bond, were found reduced 31 .
GULP1
was reduced on Cys115 by TXNRD1. Interestingly, GULP1 exists as a dimer in vivo 32 and we noted the increased monomer levels for this protein upon incubation with TXNRD1+NADPH
( Supplementary Fig. 1c-d) . We however could not confirm the reduction of GSTO1 and PRDX6. Although this might be due to the absence of certain peptides in the MS data, one could estimate the false positive rate to be not higher than ~30%. The fact that PRDX2 was detected here as a direct substrates for TXNRD1 showed that the enzyme has a capacity to also directly reduce these protein disulfides to some extent; alternatively traces of TXN present in the lysate could have been thought sufficient to facilitate this reaction because PRDX proteins are highly abundant. However, the validation redox proteomics experiment in Fig. 2f showed that TXNRD1+NADPH alone can indeed reduce PRDX2.
There were a number of proteins which were stabilized in the TXNRD1+NAPDH treatment, such as CYB5R2 and ACADM. This stabilization might be due to the protein interaction with the reduced form of TXNRD1, or by reduced species of these protein substrates forming other more thermostable states. TXN and TXNDC17, two known substrates of TXNRD1 33 , were absent in the SIESTA output due to their melting behavior. For example, although TXN was quantified in all replicates, it remained 63% soluble on average even at 67°C. Therefore, it
was not possible to measure its Tm by fitting a sigmoid curve, and thus TXN was automatically excluded from analysis (TXN also did not melt well in PARP10 and AKT1 experiments in HCT116 and HELA cells, respectively). Thioredoxin reductase is also known to reduce GLRX2
and protein disulfide isomerase (PDI) in the literature. GLRX2 did not shift in our SIESTA experiment. We quantified all 6 PDIAs in our experiment, of which only PDIA6 was destabilized by -0.69°C and was therefore excluded by our criteria. Whether these two proteins are substrates of the human TXNRD1 is yet to be seen. Therefore, considering only TXN, TXNL1, NXN and TXNDC17 as known substrates of TXNRD1, SIESTA had a false negative rate of 50% in this system. 
GSTO2 (Cys243)
SIFQGFLNLYFQNNPNAFDFGLC P < 0.002 P < 0.002 LVQAFQYTDEHGEVCPAGWK P < 0.001 P < 0.010 YVVLFFYPLDFTFVCPTEIIAFSNR P < 0.001 P < 0.001 P < 0.003 P < 0.059 
SIESTA identified and ranked many novel putative substrates for protein kinase B (AKT1)
We decided to confirm the utility of SIESTA for phosphorylation as a ubiquitous and small modification. We chose the AKT1 (protein kinase B) as a model system due to its importance in metabolism, proliferation, cell survival, growth and angiogenesis. In AKT1
SIESTA experiment (data in Supplementary Data 6), ATP was used at 500 µM, at which concentration it only acts as a cosubstrate Fig. 2c ).
To further validate a number of putative substrates, we incubated recombinant PLEKHF2 and TRAPPC2L with AKT1+ATP under the exact conditions as in SIESTA. PLEKHF2
is already known to interact with AKT1 38 . Tracking phosphate release from these recombinant proteins confirmed their modification by AKT1 (Supplementary Fig. 2d ). We chose this approach over phosphoproteomics, as the former will detect phosphorylation present in any peptide belonging to the protein, and not only single phosphopeptides. Representative melting curves for known and putative AKT1 substrates.
SIESTA identified and ranked many novel putative substrates for PARP10
We next selected the poly-(ADP-ribose) polymerase-10 (PARP10) system that performs mono-ADP ribosylation of proteins 39 . ADP-ribosylation is involved in cell signaling, DNA repair, gene regulation and apoptosis. Identification of PARP family substrates by mass spectrometry has generally proven challenging, as ADP-ribosylation is a glycosidic modification that can be easily lost during protein extraction or sample processing. It is also highly labile in the gas phase, which hampers its detection by MS/MS. Different strategies have thus been used to enrich the modified peptides for mass spectrometric analysis and use "gentle" MS/MS methods 40, 41 . Although the identification of ADP-ribosylated substrates has been challenging for other techniques, since it is a large modification, it should be amenable to SIESTA. Table 1 ). The ETD MS/MS spectrum of a peptide with Glu110 is shown in Fig. 4c and the other sites are shown in Supplementary Fig.   4a -b. The RFK sequence coverage was 94%, and ADP ribose moieties were found in three positions: on Glu140, Glu131 and Glu113, ordered from highest to lowest peptide score (Supplementary Table 1 ). The ETD MS/MS spectrum of the peptide with highest score is shown in Supplementary Fig. 3d and the other sites are shown in Supplementary Fig. 4c-d .
For HDAC2 and PIN4, the sequence coverage with trypsin digestion was not complete.
Consequently, the ADP-ribosylation of HDAC2, PIN4 as well as PDRG1 and RFK was verified using a chemiluminescence assay (Supplementary Fig. 3e ).
CASP6 (caspase-6) showed the strongest specific stabilization (ΔTm of 7.7°C, Fig.   4a,b) , but its modification was not verified in either of the two in vitro assays. It should also be noted that PARP10 was suggested to be a substrate for caspase-6 during apoptosis 44 .
PARP10 has a major cleavage site at Asp406 that is preferentially recognized by caspase-6 44 .
The strong specific thermal stabilization might therefore indicate that PARP10 induces a conformational change in caspase-6 and thus an increase in its stability by binding, as has been reported for other caspase-6 substrates 45 . The reason why caspase-6 stabilization was not observed upon PARP10 addition in the absence of NAD is that auto-modified PARP10 is required for effective caspase-6 binding 44 . With four out of five proteins being validated as PARP10 substrates (except for caspase-6), the false positive rate of SIESTA would be 20% in this system.
DISCUSSION
We demonstrate SIESTA to be a general approach for unbiased identification and prioritization of functional protein substrates for specific enzymes in a proteome-wide manner.
We uncovered a number of known or novel candidates for TXNRD1, AKT1 and PARP10 enzymes, implicating them in important cellular processes. Applying the "HotSpot" ideology to rank the putative substrates, SIESTA can be useful in uncovering the biophysical consequences of PTMs, as it can provide the most plausible substrates for functional validation. Besides the use in fundamental research, SIESTA can also facilitate drug development by discovery of substrates that can be used in screening for enzyme inhibitors.
Here we show the applicability of SIESTA for three distinct enzymes, and the utility of SIESTA for other enzyme systems will have to be established in further studies. It can probably be hypothesized that any modification will have some effect on protein stability, even though some of these changes may be too minute to be detected. Such substrates can be likely discovered via improving the statistical power, e.g., by adding more biological replicates.
While SIESTA will discover only substrates that significantly change their thermal stability upon modification, according to HotSpot conjecture such substrates are more likely to be biologically relevant. This makes it difficult to compare SIESTA results with those obtained by other methods that typically lack such ranking ability. Technically, the SIESTA, false positive substrate discovery rate for TXNRD1 and PARP10 enzymes was around 30 and 20%, respectively. Since different PTMs induce thermal shifts of different magnitudes, the falsepositive and -negative rates will be dependent on the enzyme under study. The false negative rate for TXNRD1, the enzyme inducing large shifts, could be estimated as ≈50% (this is while we identified 78 substrates, compared to 4 known substrates in the literature), while the value must be higher for the AKT1 system, as majority of phosphorylation events do not have large impact on protein stability 46 . It must however be noted that we used a 1 substrates in human cells 47, 48 , only have 6 overlapping substrates with PhosphoSitePlus database 49 .
Unlike the original HotSpot approach that compares the shifts of individual modified peptides with those of the whole bulk protein, thus identifying modifications that may or may not have significant occupancies, SIESTA compares the shift of the whole bulk protein with and without the enzyme and the cofactor, thus requiring the majority of protein molecules to be modified to be identified as substrate. Therefore, highly ranked SIESTA hits are less likely to fail in subsequent functional validation.
The spatial resolution of the method can be increased by sub-cellular fractionation of the lysate prior to analysis. Furthermore, cell-or tissue-specific substrates should be possible to discover by comparing lysates from different sources. Since the addition of enzyme in excess can cause non-physiological modifications, the identified candidates should be validated by other techniques, as suggested in Fig. 1 . Mild detergents such as NP40 can be used to increase the representation of membrane proteins in SIESTA 50 . On the other hand, the number of missing values can be reduced by using our high-throughput approach to thermal profiling, Proteome Integral Solubility Alteration (PISA) assay 51 . It has also been suggested that the final stability of a given protein is governed the detailed energetics of the proteoforms 60 .
Summarizing, the ease, breadth and speed of identifying enzyme-specific substrates offered by SIESTA can enhance our understanding of enzyme systems and disease, accelerate constructing high-throughput assays and thus facilitate drug discovery.
METHODS
Cell culture
Human colorectal carcinoma HCT116 (ATCC, USA) cells were grown at 37°C in 5% CO2 using McCoy's 5A modified medium (Sigma-Aldrich, USA) supplemented with 10% FBS superior (Biochrom, Berlin, Germany), 2 mM L-glutamine (Lonza, Wakersville, MD, USA) and 100 units/mL penicillin/streptomycin (Gibco, Invitrogen). Human A549 cells (ATCC, USA) were grown under the exact same conditions in DMEM. Low-number passages (<10) were used for the experiments.
Recombinant proteins
Human TXNRD1, GPX1 and GPX4 were expressed recombinantly in E. coli and purified as described earlier 61 . PARP10 full length protein (used in SIESTA) and catalytic domain construct (used in validation assays) were produced as detailed before 62 . The rest of the recombinant proteins were purchased and are listed in Supplementary Table 2 .
SIESTA experiment
Cells were cultured in 175 cm 2 flasks, and were then trypsinized, washed twice with PBS, resuspended in 50 mM HEPES pH 7.5, 2 mM EDTA (for TXNRD1) or in 50 mM HEPES pH 7.5, 100 mM NaCl and 4 mM MgCl2 (for PARP10), both with complete protease inhibitor cocktail (Roche). For AKT1 experiment, phosphatase inhibitors (PhosSTOP, Sigma) were also added. Cells were lysed by five freeze-thaw cycles. The cell lysates were centrifuged at 21,000
g for 20 min and the soluble fraction was collected. The protein concentration in the lysate was measured using Pierce BCA assay (Thermo) and equally distributed into 8 aliquots (1 mL each). using Pierce BCA Protein Assay Kit (Thermo), the same volume corresponding to 50 µg of protein at lowest temperature points was transferred from each sample to new tubes and urea was added to a final concentration of 4M. Dithiothreitol (DTT) was added to a final concentration of 10 mM and samples were incubated for 1 h at room temperature. Subsequently, iodoacetamide (IAA) was added to a final concentration of 50 mM and samples were incubated in room temperature for 1 h in the dark. The reaction was quenched by adding an additional 10 mM of DTT. Proteins were precipitated using methanol/chloroform. The dry protein pellet was dissolved in 8M urea, 20 mM EPPS (pH=8.5) and diluted to 4M urea. LysC was added at a 1 : 100 w/w ratio at room temperature overnight. Samples were diluted with 20mM EPPS to the final urea concentration of 1M, and trypsin was added at a 1 : 100 w/w ratio, followed by incubation for 6 h at room temperature. Acetonitrile (ACN) was added to a final concentration of 20% and TMT reagents were added 4x by weight to each sample, followed by incubation for 2 h at room temperature. The reaction was quenched by addition of 0.5% hydroxylamine. Samples were combined, acidified by TFA, cleaned using Sep-PaK cartridges (Waters) and dried using DNA 120 SpeedVac™ Concentrator (Thermo). The SIESTA samples for TXNRD1 and PARP10
were then resuspended in 0.1% TFA and fractionated into 8 fractions using Pierce™ High pH 
Sequential iodoTMT labeling
The proteins (2 µg each, in triplicates) were incubated with 1 mM NADPH, 1 µM TXNRD1, or with TXNRD1+NADPH at 37°C for 30 min. After solubilization in methanol, 4.4 mmol/L of iodoTMT was added to the samples (labels 126, 127 and 128 to replicate 1, 2 and 3 in each treatment) and incubated for 1h at 37°C with vortexing in the dark (free SH and SSH groups will be blocked in this stage). The proteins were precipitated using methanol chloroform and after drying, samples were dissolved in Tris buffer with 1% SDS and incubated at 37°C in the dark with 1 mM DTT for 1h. Subsequently, the samples were incubated with 4.4 mmol/L of the second iodoTMT label at 37°C in the dark for 1h (labels 129, 130 and 131 to replicates 1, 2 and 3 in each treatment). The reaction was quenched by 20 mM final concentration of DTT.
NADPH, TXNRD1 and TXNRD1+NADPH-treated samples were then individually pooled and precipitated. Protein pellets were dissolved in Tris and urea 8M. The samples were then diluted to 4M urea, and lysC was added at a ratio of 1:100 enzyme: protein overnight. After dilution of urea to 1M, trypsin was added at a ratio of 1:100, followed by incubation for 6 h at 37°C.
Samples were acidified by TFA and cleaned using SepPak and lyophilized using a vacuum concentrator. Samples were dissolved in 0.1% FA and 1 µg of each samples was analyzed with a Q Exactive instrument using a 2 h gradient.
LC-MS/MS
After drying, samples were dissolved in buffer A (0.1% formic acid and 2% ACN in water). The TXNRD1 and PARP10 samples were loaded onto a 50 cm EASY-Spray column (75 µm internal diameter, packed with PepMap C18, 2 µm beads, 100 Å pore size) connected to the EASY-nLC 1000 (Thermo) and eluted with a buffer B (98% ACN, 0.1% FA, 2% H2O) gradient from 5% to 38% of at a flow rate of 250 nL/min. The eluent was ionized by electrospray, with molecular ions entering an Orbitrap Fusion mass spectrometer (Thermo).
The AKT1 samples were loaded with buffer A onto a 50 cm EASY-Spray column connected to a nanoflow Dionex UltiMate 3000 UHPLC system (Thermo) and eluted in an 
Data processing
The raw LC-MS data (SIESTA) were analyzed by MaxQuant, version 1.5.6.5 63 . The
Andromeda search engine matched MS/MS data against the Uniprot complete proteome database (human, version UP000005640_9606, 92957 entries). TMT10-plex on the MS/MS level was used for quantification of protein abundances. Cysteine carbamidomethylation was used as a fixed modification, while methionine oxidation was selected as a variable modification.
In the AKT1 experiments, phosphorylation on serine and threonine was selected as variable modification, and used in quantification. For sequential iodoTMT labeling, TMT6-plex on the MS/MS level was used for quantification of peptide/protein abundances. Methionine oxidation was selected as a variable modification and a customized .fasta file with recombinant protein sequences was used. Trypsin/P was selected as enzyme specificity. No more than two missed cleavages were allowed. A 1% false discovery rate was used as a filter at both protein and peptide levels. For all other parameters, the default settings were used. After removing all the contaminants, only proteins with at least two peptides were included in the final dataset.
Network mapping
For pathway analyses, STRING version 10.5 (http://string-db.org) protein network analysis tool was used with default parameters 64 .
Validation of mono-ADP-ribosylation by targeted tandem mass spectrometry
Recombinant RFK (5 µg) and PDRG1 (5 µg 
In vitro mono-ADP-ribosylation assay
Hexahistidine-tagged PARP10 catalytic domain (auto-modification) or protein substrate (substrate protein modification) was immobilized on Ni 2+ -chelating microplates (5-PRIME). TEVcleaved PARP10 catalytic domain was used for evaluation of substrate protein modification.
Mono-ADP-ribosylation was assessed after incubation with 100 µM NAD + (including 2% biotinylated NAD + , Trevigen) prior to chemiluminescence detection of biotinyl-ADP-ribose in a
Clariostar microplate reader (BMG Labtech) as described in detail before 62 .
Phosphoprotein Phosphate Estimation Assay
The recombinant proteins were incubated with AKT1 and ATP under exact condition of SIESTA experiment. Samples treated with only AKT1 or ATP were used as controls. Phosphate release from the proteins was measured by the Phosphoprotein Phosphate Estimation Assay Kit (Thermo) according the manufacturer instructions. The absorbance was measured at 620 nm using an Epoch Microplate Spectrophotometer (BioTek).
SDS-PAGE
GULP1 (3 µg) was incubated with NADPH (1 mM), TXNRD1 (1 µM) or their combination for 30 min at 37°C in triplicates. After addition of the NuPAGE LDS Sample Buffer (Thermo), the samples were loaded in a NuPAGE Bis-Tris Mini Gel (Thermo) with 10 lanes and separated on a NuPAGE Bis-Tris 4-12% gel in MOPS SDS Running Buffer under non-reducing conditions at 200V for 60 min using the XCell SureLock system (Thermo). SeeBlue Plus2 Pre-stained Protein Standard (Thermo) was used as a ladder. The gel was then washed and stained with Coomassie blue for 1 h and then destained overnight. The resulting protein bands were captured using Universal Hood II (Bio-Rad) and analyzed using Quantity One 4.6.9.
Statistical Analysis
Curve normalization and fitting was done by an in-house R package (https://github.com/RZlab/SIESTA). Briefly, after removing the contaminant proteins and those quantified with less than two peptides, protein abundances in temperature points 41-67°C were normalized to the total proteome melting curve similar to Franken at al. 30 . For each protein in each replicate, a sigmoid curve was fitted using non-linear least squares method according the formula: Multivariate modeling using OPLS-DA was performed using SIMCA 15.0. Protein loading scores were validated using the VIP values at 95% confidence.
Two-tailed Student t-test (with equal or unequal variance depending on F-test) was applied to calculate p values, unless otherwise specified.
Code availability
The curve fitting R package is available in GitHub (https://github.com/RZlab/SIESTA) with no access restrictions.
Data availability
Excel files containing the analyzed data are provided in Supplementary Materials. The mass spectrometry data were deposited to the ProteomeXchange Consortium 
